CAR T-Cell Therapy for Non-Hodgkin Lymphoma | Cancer Q&A — Discussing Common Questions Posed by Patients
Hematologic Oncology Update
00:00
Integrating CAR T into mantle cell lymphoma
Discussion of brexucabtagene and liso-cel for MCL, toxicity concerns and BTK inhibitor sequencing.
Play episode from 23:56
Transcript
